BIOT
Biotech Acquisition Company Class A Ordinary Shares
BIOT
BIOT
Delisted
BIOT was delisted on the 2nd of February, 2023.
67 hedge funds and large institutions have $218M invested in Biotech Acquisition Company Class A Ordinary Shares in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
67
Holders Change
-9
Holders Change %
-11.84%
% of All Funds
1.13%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
9
Increased
13
Reduced
13
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
![]()
JPMorgan Chase & Co
New York
|
$20M |
2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
$12.5M |
3 |
GCL
Glazer Capital LLC
New York
|
$6.3M |
4 |
RL
RPO LLC
Stamford,
Connecticut
|
$6.22M |
5 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
$3.48M |